Literature DB >> 11216644

Thyroid-associated ophthalmopathy in black South Africans with Graves' disease: relationship to serum antibodies reactive against eye muscle and orbital connective tissue autoantigens.

B I Joffe1, V R Panz, M Yamada, J R Wall.   

Abstract

The prevalence of hyperthyroidism owing to Graves' disease is increasing among urban black South Africans. Thyroid-associated ophthalmopathy is often observed in this context, but its pathogenesis remains unclear. No close relationship has been noted between antiflavoprotein (Fp) antibodies or thyrotropin receptor antibodies and ocular involvement in black patients. We measured serum antibodies against eye muscle and orbital connective tissue antigens in black patients with Graves' disease, correlating them with eye signs. Of 11 patients with clinical ophthalmopathy, 2 (18%) had antibodies against collagen type XIII, 3 (27%) against flavine adenine dinucleotide (FAD), 1 (9%) against Fp, and 4 (35%) against G2s. Antibody prevalences in eight patients without clinical ophthalmopathy were 12.5% for collagen XIII, 12.5% for FAD, 25% for Fp and 0% for G2s. These differences were not statistically significant. None of the individual mean antibody levels were significantly different between the two subgroups of thyrotoxic patients. Serum antibody levels were negative in 10 black South African controls. In summary, eye muscle and orbital connective tissue antibodies were found in small proportions of patients with Graves' disease with no close relationship of any antibody to eye signs. Thus, a substantial proportion of black South Africans with overt clinical ophthalmopathy remains in whom currently availabe serologic tests are unhelpful for screening and laboratory confirmation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11216644     DOI: 10.1385/endo:13:3:325

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  16 in total

1.  Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.

Authors:  K Gunji; A De Bellis; A W Li; M Yamada; S Kubota; B Ackrell; S Wengrowicz; A Bellastella; A Bizzarro; A Sinisi; J R Wall
Journal:  J Clin Endocrinol Metab       Date:  2000-04       Impact factor: 5.958

2.  Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.

Authors:  K Gunji; A De Bellis; S Kubota; J Swanson; S Wengrowicz; B Cochran; B A Ackrell; M Salvi; A Bellastella; A Bizzarro; A A Sinisi; J R Wall
Journal:  J Clin Endocrinol Metab       Date:  1999-04       Impact factor: 5.958

3.  Classification of eye changes of Graves' disease.

Authors: 
Journal:  Thyroid       Date:  1992       Impact factor: 6.568

4.  Eye muscle membrane reactive antibodies are not detected in the serum or immunoglobulin fraction of patients with thyroid-associated ophthalmopathy using an ELISA and crude membranes.

Authors:  M Kapusta; M Salvi; H Triller; E Gardini; N Bernard; J R Wall
Journal:  Autoimmunity       Date:  1990       Impact factor: 2.815

5.  Experience with carbimazole in the treatment of the hyperthyroidism of Graves' disease in Nigerian patients.

Authors:  O Modebe
Journal:  Afr J Med Med Sci       Date:  1995-12

Review 6.  Two new collagen subgroups: membrane-associated collagens and types XV and XVII.

Authors:  T Pihlajaniemi; M Rehn
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1995

7.  Thyrotoxicosis in urban black Africans: a rising incidence.

Authors:  W J Kalk
Journal:  East Afr Med J       Date:  1981-02

8.  Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases.

Authors:  Y J Wu; E M Clarke; P Shepherd
Journal:  Thyroid       Date:  1998-02       Impact factor: 6.568

9.  Evaluation of an enzyme-linked immunosorbent assay for the measurement of autoantibodies against eye muscle membrane antigens in Graves' ophthalmopathy.

Authors:  A Miller; H Sikorska; M Salvi; J R Wall
Journal:  Acta Endocrinol (Copenh)       Date:  1986-12

10.  Thyrotropin receptor antibodies in black South African patients with Graves' disease and their response to medical therapy.

Authors:  M Zouvanis; V R Panz; W J Kalk; B I Joffe
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

View more
  2 in total

1.  Altered spontaneous brain activity patterns in patients with hyperthyroidism exophthalmos using amplitude of low-frequency fluctuation: a resting-state fMRI study.

Authors:  Ling Ling; Wen-Feng Liu; Yu Guo; Rong-Bin Liang; Hui-Ye Shu; Li-Juan Zhang; Qiu-Yu Li; Qian-Min Ge; Yi-Cong Pan; Yi Shao
Journal:  Int J Ophthalmol       Date:  2021-12-18       Impact factor: 1.779

Review 2.  Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?

Authors:  T Mizokami; M Salvi; J R Wall
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.